Basement Membrane Localized Tumor Cells Are Protected from HER2-Targeted Therapy In Vivo.

被引:0
|
作者
Zoeller, J. J. [1 ]
Bronson, R. T. [1 ]
Gilmer, T. M. [1 ]
Selfors, L. M. [1 ]
Lu, Y. [1 ]
Mills, G. B. [1 ]
Brugge, J. S. [1 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1158/0008-5472.SABCS11-S5-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S5-3
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo.
    Zoeller, J. J.
    Bronson, R. T.
    Gilmer, T. M.
    Selfors, L. M.
    Lu, Y.
    Apple, S. K.
    Press, M. F.
    Hurvitz, S. A.
    Slamon, D. J.
    Mills, G. B.
    Brugge, J. S.
    CANCER RESEARCH, 2012, 72
  • [2] Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo
    Zoeller, Jason J.
    Bronson, Roderick T.
    Gilmer, Tona M.
    Selfors, Laura M.
    Lu, Yiling
    Mills, Gordon B.
    Brugge, Joan S.
    CANCER RESEARCH, 2012, 72
  • [3] Basement membrane-localized tumor cells are protected from HER2-targeted therapy in vivo
    Zoeller, Jason
    Bronson, Roderick
    Gilmer, Tona
    Selfors, Laura
    Lu, Yiling
    Apple, Sophia
    Press, Michael
    Hurvitz, Sara
    Slamon, Dennis
    Mills, Gordon
    Brugge, Joan
    GLYCOBIOLOGY, 2012, 22 (11) : 1531 - 1532
  • [4] Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
    Zoeller, Jason J.
    Bronson, Roderick T.
    Selfors, Laura M.
    Mills, Gordon B.
    Brugge, Joan S.
    NPJ BREAST CANCER, 2017, 3
  • [5] Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
    Jason J. Zoeller
    Roderick T. Bronson
    Laura M. Selfors
    Gordon B. Mills
    Joan S. Brugge
    npj Breast Cancer, 3
  • [6] Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
    Jason J. Zoeller
    Roderick T. Bronson
    Laura M. Selfors
    Gordon B. Mills
    Joan S. Brugge
    npj Breast Cancer, 3
  • [7] Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo (vol 3, 18, 2017)
    Zoeller, Jason J.
    Bronson, Roderick T.
    Selfors, Laura M.
    Mills, Gordon B.
    Brugge, Joan S.
    NPJ BREAST CANCER, 2017, 3
  • [8] HER2-targeted Tumor immunotherapy
    Wei, Huafeng
    Guo, Yajun
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 325 - 325
  • [9] HER2-targeted therapy is changing
    Matsumura, Noriomi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 325 - 325
  • [10] HER2-Targeted Therapy in Osteosarcoma
    Gill, Jonathan
    Hingorani, Pooja
    Roth, Michael
    Gorlick, Richard
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 55 - 66